WHO: Ebola vaccine trial to launch in DR Congo within weeks

Source Summary

The World Health Organization announced that the first clinical trial of an Ebola vaccine is expected to begin in the Democratic Republic of Congo by the end of October. WHO experts confirmed the timeline on Tuesday.

Why it matters

A clinical vaccine trial represents a critical step toward developing a preventive treatment for Ebola, a disease with high mortality rates in affected regions.